Curated data in life sciences: the cornerstone of research readiness and precision
This is part three of a three-part series on the essential qualities of claims data for life...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists...
This is part three of a three-part series on the essential qualities of claims data for life...
This is part two of a three-part series (read part 1, part 3) on the essential qualities of claims...
This is part one of a three-part series (read part 2, part 3) on the essential qualities of claims...
The problem with Zombie Data—And the critical need for Verified Data In life sciences, where...
Key benefits of real-world lab data for life sciences and pharma Real-world lab results enhance...
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial...
The one constant in healthcare marketing is change, particularly in four key areas: Evolving...
In the evolving world of real-world data (RWD), pharmaceutical companies are increasingly focused...
In our series exploring the benefits, considerations and use cases for various types of real-world...
Background of the CRWDi project While the COVID-19 pandemic is behind us, the virus remains a...
Healthcare claims data are one of the most powerful sources of data in generating real-world evidence (RWE). These data help answer questions about therapeutic area incidence and prevalence, healthcare resource utilization and costs, treatment patter...